Find Research outputs

Search results

• 2020

  Advances and considerations in AD tau-targeted immunotherapy

  Bittar, A., Bhatt, N. & Kayed, R., Feb 2020, In: Neurobiology of Disease. 134, 104707.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Immunotherapy
  • Alzheimer Disease
  • tau Proteins
  • Amyloid
  • Direction compound
  15 Scopus citations

• Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers

  Singh, A., Allen, D., Fracassi, A., Tumurbaatar, B., Natarajan, C., Scaduto, P., Woltjer, R., Kayed, R., Limon, A., Krishnan, B., Taglialatela, G. & Abisambra, J., 2020, In: Journal of Alzheimer's Disease. 78, 4, p. 1661-1678 18 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neuropathology
  • Synapses
  • Alzheimer Disease
  • Central Nervous System
  • Cognitive Dysfunction

• Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies

  Puangmalai, N., Bhatt, N., Montalbano, M., Sengupta, U., Gaikwad, S., Ventura, F., McAllen, S., Ellsworth, A., Garcia, S. & Kayed, R., May 1 2020, In: Cell Death and Disease. 11, 5, 314.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Progressive Supranuclear Palsy
  • Lewy Body Disease
  • Heparan Sulfate Proteoglycans
  • Alzheimer Disease
  • Brain
  15 Scopus citations

• Modulating disease-relevant tau oligomeric strains by small molecules

  Cascio, F. L., Garcia, S., Montalbano, M., Puangmalai, N., McAllen, S., Pace, A., Piccionello, A. P. & Kayed, R., Oct 30 2020, In: Journal of Biological Chemistry. 295, 44, p. 14807-14825 19 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Oligomers
  • Tauopathies
  • Molecules
  • Brain
  • Agglomeration
  2 Scopus citations

• P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease

  Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. & Kayed, R., Aug 10 2020, In: Acta Neuropathologica Communications. 8, 1, 132.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • DNA Damage
  • Alzheimer Disease
  • Brain
  • Neurodegenerative Diseases
  • Transcription Factors
  6 Scopus citations

• Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein

  Sengupta, U., Puangmalai, N., Bhatt, N., Garcia, S., Zhao, Y. & Kayed, R., Jun 1 2020, In: Molecular Neurobiology. 57, 6, p. 2741-2765 25 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Synucleins
  • tau Proteins
  • Docosahexaenoic Acids
  • Parkinson Disease
  • Dopamine
  3 Scopus citations

• Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective

  Derry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A. L. & Kent, T. A., Jan 2020, In: Progress in Neurobiology. 184, 101716.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Amyloid
  • Iron
  • Alzheimer Disease
  • Metals
  • Oxidative Stress
  14 Scopus citations

• RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction

  Montalbano, M., McAllen, S., Puangmalai, N., Sengupta, U., Bhatt, N., Johnson, O. D., Kharas, M. G. & Kayed, R., Dec 1 2020, In: Nature communications. 11, 1, 4305.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • RNA-Binding Proteins
  • proteins
  • Alzheimer Disease
  • Frontotemporal Dementia With Motor Neuron Disease
  • Neurodegenerative diseases
  5 Scopus citations

• Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk

  Kayed, R., Dettmer, U. & Lesné, S. E., 2020, In: Journal of Parkinson's Disease. 10, 3, p. 791-818 28 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Synucleins
  • Neurodegenerative Diseases
  • Amyloidogenic Proteins
  • Multiple System Atrophy
  • Lewy Body Disease
  1 Scopus citations

• TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia

  Montalbano, M., McAllen, S., Cascio, F. L., Sengupta, U., Garcia, S., Bhatt, N., Ellsworth, A., Heidelman, E. A., Johnson, O. D., Doskocil, S. & Kayed, R., Dec 2020, In: Neurobiology of Disease. 146, 105130.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Frontotemporal Dementia With Motor Neuron Disease
  • DNA-Binding Proteins
  • Alzheimer Disease
  • Inclusion Bodies
  • Neurodegenerative Diseases
• 2018

  AAV2-mediated GRP78 transfer alleviates retinal neuronal injury by downregulating ER stress and Tau oligomer formation

  Ha, Y., Liu, W., Liu, H., Zhu, S., Xia, F., Gerson, J. E., Azhar, N. A., Tilton, R. G., Motamedi, M., Kayed, R. & Zhang, W., Sep 2018, In: Investigative Ophthalmology and Visual Science. 59, 11, p. 4670-4682 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Nerve Crush
  • Retinal Ganglion Cells
  • Endoplasmic Reticulum Stress
  • Optic Nerve
  • Down-Regulation
  6 Scopus citations

• Azure C Targets and Modulates Toxic Tau Oligomers

  Lo Cascio, F. & Kayed, R., Jun 20 2018, In: ACS chemical neuroscience. 9, 6, p. 1317-1326 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Azure C
  • Oligomers
  • Poisons
  • Alzheimer Disease
  • Toxicity
  17 Scopus citations

• Binding and neurotoxicity mitigation of toxic tau oligomers by synthetic heparin like oligosaccharides

  Wang, P., Lo Cascio, F., Gao, J., Kayed, R. & Huang, X., 2018, In: Chemical Communications. 54, 72, p. 10120-10123 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Oligosaccharides
  • Heparin
  • Oligomers
  • Poisons
  • Cytotoxicity
  10 Scopus citations

• Elevated phospholipase D isoform 1 in Alzheimer's disease patients’ hippocampus: Relevance to synaptic dysfunction and memory deficits

  Krishnan, B., Kayed, R. & Taglialatela, G., 2018, In: Alzheimer's and Dementia: Translational Research and Clinical Interventions. 4, p. 89-102 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Alzheimer disease type 1
  • Phospholipase D
  • Memory Disorders
  • Protein Isoforms
  • Hippocampus
  12 Scopus citations

• Evaluating Passive Immunotherapy using Aged Transgenic Animals of Tauopathy

  Al Lahham, R., Bittar, A., Montalbano, M., Carretero Murillo, M., McAllen, S., Bhatt, N., Ellsworth, A. & Kayed, R., Apr 2018, (Unpublished).

  Research output: Contribution to conference › Poster › peer-review

• Evaluating Tau Oligomers Passive Immunotherapy using Aged Transgenic Animals of Tauopathy

  Al Lahham, R., Bittar, A., Montalbano, M., Carretero Murillo, M., McAllen, S., Bhatt, N., Ellsworth, A. & Kayed, R., Jul 2018, In: Alzheimer's and Dementia. 14, 7, p. 1657

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer's disease

  Sengupta, U., Montalbano, M., McAllen, S., Minuesa, G., Kharas, M. & Kayed, R., Oct 26 2018, In: Acta Neuropathologica Communications. 6, 1, p. 113 1 p.

  Research output: Contribution to journal › Article › peer-review

  • RNA-Binding Proteins
  • Alzheimer Disease
  • Poisons
  • Brain
  • Proteins
  9 Scopus citations

• Immunotherapy Targeting Tau Oligomeric Strains in Aged Transgenic Animals of Tauopathy

  Al Lahham, R., Bittar, A., Carretero Murillo, M., McAllen, S., Bhatt, N., Ellsworth, A. & Kayed, R., Oct 2018, p. S64.

  Research output: Contribution to conference › Abstract › peer-review

  • Tauopathies
  • Genetically Modified Animals
  • Passive Immunization
  • Immunotherapy
  • Clone Cells

• Preparation and characterization of tau oligomer strains

  Sengupta, U., Carretero-Murillo, M. & Kayed, R., 2018, Methods in Molecular Biology. Humana Press Inc., p. 113-146 34 p. (Methods in Molecular Biology; vol. 1779).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Prion Proteins
  • In Vitro Techniques
  6 Scopus citations

• Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies

  Bittar, A., Sengupta, U. & Kayed, R., Dec 1 2018, In: npj Vaccines. 3, 1, 9.

  Research output: Contribution to journal › Article › peer-review

  • Tauopathies
  • Passive Immunization
  • Immunotherapy
  • Alzheimer Disease
  • Poisons
  25 Scopus citations

• Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior

  Ghag, G., Bhatt, N., Cantu, D. V., Guerrero-Munoz, M. J., Ellsworth, A., Sengupta, U. & Kayed, R., Nov 2018, In: Protein Science. 27, 11, p. 1901-1909 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Sonication
  • Poisons
  • Oligomers
  • Amyloidogenic Proteins
  • Prions
  26 Scopus citations

• Tau Immunotherapy for Alpha-Synucleinopathy

  Aguilar, C., Al Lahham, R., Sengupta, U., Carretero Murillo, M., Kayed, R. & Dineley, K., Jul 2018, In: Alzheimer's and Dementia. 14, 7, p. 1412

  Research output: Contribution to journal › Article › peer-review

• Tau Immunotherapy for Alpha-Synucleinopathy

  Aguilar, C., Al Lahham, R., Sengupta, U., Carretero Murillo, M., Kayed, R. & Dineley, K., Jul 2018, In: Alzheimer's and Dementia. 14, 7, p. 1442

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

  Gerson, J. E., Farmer, K. M., Henson, N., Castillo-Carranza, D. L., Carretero Murillo, M., Sengupta, U., Barrett, A. & Kayed, R., Mar 15 2018, In: Molecular Neurodegeneration. 13, 1, 13.

  Research output: Contribution to journal › Article › peer-review

  • Synucleins
  • Immunotherapy
  • Poisons
  • Monoclonal Antibodies
  • Lewy Bodies
  25 Scopus citations

• α-Synuclein Oligomers Induce a Unique Toxic Tau Strain

  Castillo-Carranza, D. L., Guerrero-Muñoz, M. J., Sengupta, U., Gerson, J. E. & Kayed, R., Oct 1 2018, In: Biological Psychiatry. 84, 7, p. 499-508 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Synucleins
  • Poisons
  • Parkinson Disease
  • Brain
  • Disease Progression
  29 Scopus citations
• 2017

  Cerebral microvascular accumulation of tau oligomers in Alzheimer's disease and related tauopathies

  Castillo-Carranza, D. L., Nilson, A. N., Van Skike, C. E., Jahrling, J. B., Patel, K., Garach, P., Gerson, J. E., Sengupta, U., Abisambra, J., Nelson, P., Troncoso, J., Ungvari, Z., Galvan, V. & Kayed, R., 2017, In: Aging and Disease. 8, 3, p. 257-266 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Tauopathies
  • Alzheimer Disease
  • Progressive Supranuclear Palsy
  • Lewy Body Disease
  • Blood Vessels
  33 Scopus citations

• Corrigendum: Pre-amyloid oligomers budding:a metastatic mechanism of proteotoxicity

  Bernini, F., Malferrari, D., Pignataro, M., Bortolotti, C. A., Di Rocco, G., Lancellotti, L., Brigatti, M. F., Kayed, R., Borsari, M., Del Monte, F. & Castellini, E., Jan 19 2017, In: Scientific reports. 7, 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Critical Role of the CXCL10/C-X-C Chemokine Receptor 3 Axis in Promoting Leukocyte Recruitment and Neuronal Injury during Traumatic Optic Neuropathy Induced by Optic Nerve Crush

  Ha, Y., Liu, H., Zhu, S., Yi, P., Liu, W., Nathanson, J., Kayed, R., Loucas, B., Sun, J., Frishman, L. J., Motamedi, M. & Zhang, W., Feb 1 2017, In: American Journal of Pathology. 187, 2, p. 352-365 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Optic Nerve Injuries
  • Nerve Crush
  • CXC Chemokines
  • Chemokine Receptors
  • Optic Nerve
  17 Scopus citations

• Evaluating Tau Oligomers Passive Immunotherapy using Aged Transgenic Animals of Tauopathy

  Al Lahham, R., Bittar, A., Carretero Murillo, M., McAllen, S., Bhatt, N., Ellsworth, A. & Kayed, R., Dec 2017, (Unpublished).

  Research output: Contribution to conference › Poster

  • Tauopathies
  • Genetically Modified Animals
  • Passive Immunization
  • Monoclonal Antibodies
  • Clone Cells

• iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases

  Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., Caraway, C. A., Fote, G. M., Madany, A. M., Agrawal, A., Kayed, R., Gylys, K. H., Cahalan, M. D., Cummings, B. J., Antel, J. P., Mortazavi, A. & 3 others, Carson, M. J., Poon, W. W. & Blurton-Jones, M., Apr 19 2017, In: Neuron. 94, 2, p. 278-293.e9

  Research output: Contribution to journal › Article › peer-review

  • Microglia
  • Alzheimer Disease
  • Brain
  • Organoids
  • Gene Expression Profiling
  264 Scopus citations

• Oligomer Formation and Cross-Seeding: The New Frontier

  Farmer, K., Gerson, J. E. & Kayed, R., Jul 2017, In: Israel Journal of Chemistry. 57, 7, p. 665-673 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Oligomers
  • Seed
  • Agglomeration
  • Protein Aggregates
  • Brain
  4 Scopus citations

• Oligomeric tau-targeted immunotherapy in Tg4510 mice

  Schroeder, S., Joly-Amado, A., Soliman, A., Sengupta, U., Kayed, R., Gordon, M. N. & Morgan, D., Jun 27 2017, In: Alzheimer's Research and Therapy. 9, 1, 46.

  Research output: Contribution to journal › Article › peer-review

  • Immunotherapy
  • Monoclonal Antibodies
  • Immunoglobulin G
  • Brain
  • Tauopathies
  7 Scopus citations

• Selective lowering of synapsins induced by oligomeric α-synuclein exacerbates memory deficits

  Larson, M. E., Greimel, S. J., Amar, F., LaCroix, M., Boyle, G., Sherman, M. A., Schley, H., Miel, C., Schneider, J. A., Kayed, R., Benfenati, F., Lee, M. K., Bennett, D. A. & Lesné, S. E., Jun 6 2017, In: Proceedings of the National Academy of Sciences of the United States of America. 114, 23, p. E4648-E4657

  Research output: Contribution to journal › Article › peer-review

  • Synucleins
  • Synapsins
  • Memory Disorders
  • Amyloidogenic Proteins
  • Response Elements
  25 Scopus citations

• Tau oligomers as pathogenic seeds: Preparation and propagation in vitro and in vivo

  Gerson, J. E., Sengupta, U. & Kayed, R., 2017, Methods in Molecular Biology. Humana Press Inc., p. 141-157 17 p. (Methods in Molecular Biology; vol. 1523).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Seeds
  • In Vitro Techniques
  • Neurodegenerative Diseases
  • Poisons
  • Antibodies
  16 Scopus citations

• Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases

  Nilson, A. N., English, K. C., Gerson, J. E., Barton Whittle, T., Nicolas Crain, C., Xue, J., Sengupta, U., Castillo-Carranza, D. L., Zhang, W., Gupta, P. & Kayed, R., 2017, In: Journal of Alzheimer's Disease. 55, 3, p. 1083-1099 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Tauopathies
  • Encephalitis
  • Neurodegenerative Diseases
  • Retina
  • Inflammation
  51 Scopus citations

• Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls

  Kolarova, M., Sengupta, U., Bartos, A., Ricny, J. & Kayed, R., 2017, In: Journal of Alzheimer's Disease. 58, 2, p. 471-478 8 p.

  Research output: Contribution to journal › Article › peer-review

  • tau Proteins
  • Cognitive Dysfunction
  • Alzheimer Disease
  • Serum
  • Extracellular Space
  12 Scopus citations

• The Potential of Small Molecules in Preventing Tau Oligomer Formation and Toxicity

  Gerson, J. E., Lo Cascio, F. & Kayed, R., Jan 20 2017, Neuroprotection in Alzheimer's Disease. Elsevier Inc., p. 97-121 25 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Amyloid
  • Neurodegenerative Diseases
  • Poisons
  • Tauopathies
  • Amyloidogenic Proteins
  1 Scopus citations
• 2016

  Advances in tau immunotherapy

  Gerson, J. & Kayed, R., Jan 1 2016, Research Progress in Alzheimer’s Disease and Dementia. Volume 6. Nova Science Publishers, Inc., p. 99-114 16 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Toxicity
  • Alzheimer's Disease
  • Protein
  • Vaccination
  • Antibody

• Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart

  Troncone, L., Luciani, M., Coggins, M., Wilker, E. H., Ho, C. Y., Codispoti, K. E., Frosch, M. P., Kayed, R. & del Monte, F., Dec 6 2016, In: Journal of the American College of Cardiology. 68, 22, p. 2395-2407 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Amyloid
  • Heart Diseases
  • Alzheimer Disease
  • Heart
  • Pathology
  62 Scopus citations

• Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model

  Kim, Y. D., Choi, H., Lee, W. J., Park, H., Kam, T. I., Hong, S. H., Nah, J., Jung, S., Shin, B., Lee, H., Choi, T. Y., Choo, H., Kim, K. K., Choi, S. Y., Kayed, R. & Jung, Y. K., Mar 1 2016, In: Neurobiology of Disease. 87, p. 19-28 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Caspases
  • Transgenic Mice
  • Memory
  • Memory Disorders
  • Hippocampus
  33 Scopus citations

• Potential mechanisms and implications for the formation of tau oligomeric strains

  Gerson, J. E., Mudher, A. & Kayed, R., Nov 1 2016, In: Critical Reviews in Biochemistry and Molecular Biology. 51, 6, p. 482-496 15 p.

  Research output: Contribution to journal › Review article › peer-review

  • Prions
  • Pathology
  • Neurodegenerative diseases
  • Tauopathies
  • Neurodegenerative Diseases
  27 Scopus citations

• Pre-amyloid oligomers budding: A metastatic mechanism of proteotoxicity

  Bernini, F., Malferrari, D., Pignataro, M., Bortolotti, C. A., Di Rocco, G., Lancellotti, L., Brigatti, M. F., Kayed, R., Borsari, M., Del Monte, F. & Castellini, E., Oct 24 2016, In: Scientific reports. 6, 35865.

  Research output: Contribution to journal › Article › peer-review

  • Amyloid
  • Proteostasis Deficiencies
  • Immunoglobulin Fragments
  • Atomic Force Microscopy
  • Immunotherapy
  8 Scopus citations

• Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice

  Gerson, J., Castillo-Carranza, D. L., Sengupta, U., Bodani, R., Prough, D. S., DeWitt, D. S., Hawkins, B. E. & Kayed, R., Nov 15 2016, In: Journal of neurotrauma. 33, 22, p. 2034-2043 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Traumatic Brain Injury
  • Cognitive Dysfunction
  • Pathology
  • Brain
  • Neurodegenerative Diseases
  39 Scopus citations

• Therapeutic approaches targeting pathological tau aggregates

  Gerson, J. & Kayed, R., Jul 1 2016, In: Current Pharmaceutical Design. 22, 26, p. 4028-4039 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Poisons
  • Neurofibrillary Tangles
  • Therapeutics
  • Immunotherapy
  • Neurodegenerative Diseases
  10 Scopus citations

• The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy

  Sengupta, U., Nilson, A. N. & Kayed, R., Apr 1 2016, In: EBioMedicine. 6, p. 42-49 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Oligomers
  • Toxicity
  • Amyloid
  • Immunotherapy
  • Conformations
  269 Scopus citations
• 2015

  A native interactor scaffolds and stabilizes toxic Ataxin-1 oligomers in SCA1

  Lasagna-Reeves, C. A., Rousseaux, M. W. C., Guerrero-Munoz, M. J., Park, J., Jafar-Nejad, P., Richman, R., Lu, N., Sengupta, U., Litvinchuk, A., Orr, H. T., Kayed, R. & Zoghbi, H. Y., May 19 2015, In: eLife. 4, MAY, p. 1-46 46 p., e07558.

  Research output: Contribution to journal › Article › peer-review

  • Ataxin-1
  • Oligomers
  • Spinocerebellar Ataxias
  • Scaffolds
  • Drive
  16 Scopus citations

• Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer's Disease

  Bodani, R. U., Sengupta, U., Castillo-Carranza, D. L., Guerrero-Muñoz, M. J., Gerson, J. E., Rudra, J. & Kayed, R., Dec 16 2015, In: ACS Chemical Neuroscience. 6, 12, p. 1981-1989 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Oligomers
  • Amyloid
  • Alzheimer Disease
  • Poisons
  • Peptides
  13 Scopus citations

• Pathological Interface between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies

  Sengupta, U., Guerrero-Muñoz, M. J., Castillo-Carranza, D. L., Lasagna-Reeves, C. A., Gerson, J. E., Paulucci-Holthauzen, A. A., Krishnamurthy, S., Farhed, M., Jackson, G. R. & Kayed, R., Nov 15 2015, In: Biological Psychiatry. 78, 10, p. 672-683 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Synucleins
  • alpha-Synuclein
  • Antibodies
  • Brain
  • Lewy Body Disease
  89 Scopus citations

• Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo

  Violet, M., Chauderlier, A., Delattre, L., Tardivel, M., Chouala, M. S., Sultan, A., Marciniak, E., Humez, S., Binder, L., Kayed, R., Lefebvre, B., Bonnefoy, E., Buée, L. & Galas, M. C., Oct 1 2015, In: Neurobiology of Disease. 82, p. 540-551 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Nucleic Acids
  • Neurons
  • Induced Hyperthermia
  • Alzheimer Disease
  • Pathology
  36 Scopus citations

• Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an alzheimer’s disease mouse model

  Castillo-Carranza, D. L., Guerrero-Muñoz, M. J., Sengupta, U., Hernandez, C., Barrett, A. D. T., Dineley, K. & Kayed, R., 2015, In: Journal of Neuroscience. 35, 12, p. 4857-4868 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Amyloid
  • Immunotherapy
  • Alzheimer Disease
  • Memory Disorders
  • Pathology
  85 Scopus citations